BRG-1, an SWI/SNF complex member, is recruited to ERα-responsive regions in response to E2 stimulation and alters the histone acetyltransferase activity of the CBP/P300/PCAF complex in luminal breast cancer [55]. Here, EP300 is linked to breast carcinoma.